Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00589719 · ClinicalTrials.gov registry record
Asthma in the Delta Region of Arkansas (ADRA): Prevalence and Morbidity
A clinical trial of Asthma, sponsored by Arkansas Children's Hospital Research Institute.
- Completed
- Registry status
- 964
- Enrollment target
- 1
- Study location
NCT00589719 is a study of Asthma that has completed, run by Arkansas Children's Hospital Research Institute. The registered enrollment target is 964 participants, below the 1,561-participant average among 374 other Asthma trials with a reported enrollment target (38% lower). The trial reports 1 study location across 1 state.
The verdict
NCT00589719, a study of Asthma, has completed, sponsored by Arkansas Children's Hospital Research Institute.
- COMPLETED
- Registry status
- 964 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of the study is to conduct a cross-sectional study to examine asthma prevalence and morbidity in a predominately minority, low-income population in rural Arkansas.
Conditions Studied
Study Locations (1)
Arkansas
- Arkansas Children's Hospital Research Institute - Little Rock
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 964 participants |
| Start Date | 2005-08 |
| Est. Completion | 2008-08 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00589719
The ClinicalTrials.gov registry entry for NCT00589719 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 964 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 1,561-participant average among 374 other Asthma trials with a reported enrollment target (38% lower). The listed sponsor is Arkansas Children's Hospital Research Institute, which has 97 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Asthma appearing as the primary indexed condition, and to 0 interventions.
NCT00589719 reports 1 study location spanning 1 distinct geographic area - top geographies include Arkansas.
Frequently Asked Questions
What is clinical trial NCT00589719 about?
NCT00589719 is a clinical study titled "Asthma in the Delta Region of Arkansas (ADRA): Prevalence and Morbidity". The purpose of the study is to conduct a cross-sectional study to examine asthma prevalence and morbidity in a predominately minority, low-income population in rural Arkansas.
What is the current status of trial NCT00589719?
This trial is currently completed. The enrollment target is 964 participants. The study started on 2005-08. Estimated completion is 2008-08.
What conditions does trial NCT00589719 study?
This clinical trial studies the following conditions: Asthma.
Who is sponsoring clinical trial NCT00589719?
This trial is sponsored by Arkansas Children's Hospital Research Institute, which has 97 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00589719 being conducted?
This trial has 1 study location across Arkansas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Asthma
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Innate Immunity in Allergic Asthma
RECRUITING
-
Automated Inhaler Monitoring for Asthma Medication Usage
RECRUITING · NA
-
Impact of Metabolic Dysfunction and Mucus Plugging on Asthma Physiology
RECRUITING
-
Depemokimab Asthma Imaging and Bronchoscopy Sub-Study
RECRUITING · Phase 3
-
Escitalopram in Asthma Patients With Frequent Exacerbation
RECRUITING · Phase 2
-
Measuring the Effect of Dupilumab Treatment on Mucociliary Clearance (MCC) in Subjects With Moderate to Severe Asthma
RECRUITING · Phase 4
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.